药学一区SCI期刊推荐

分类：SCI期刊 时间：2023-12-20 17:09 关注：(1)

　　药学一区SCI期刊有哪些呢？SCI期刊是有分区划分的，根据影响因子高低划分为四个分区，分别是一区、二区、三区以及四区。其中SCI一区期刊属于学术水平比较高的刊物，对论文要求是比较高的，发表药学类SCI论文，就要选择相关的期刊投稿。接下来，详细的推荐几本SCI期刊，仅供参考。

　　1、DRUG RESISTANCE UPDATES

　　学科领域：

　　大类：医学

　　小类：药学

　　中科院分区：1区

　　期刊简介：

　　Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance.

　　《耐药性更新》是一份双月刊，其中包含关于传染病和癌症耐药性重要进展的发人深省的评论，以及克服耐药性的新药和策略。

　　2、PHARMACOLOGY & THERAPEUTICS

　　学科领域：

　　大类：医学

　　小类：药学

　　中科院分区：1区

　　期刊简介：Pharmacology & Therapeutics presents lucid, critical and authoritative reviews of currently important topics in pharmacology. Since articles are commissioned, instructions to authors are provided by the editor responsible for recruiting the work. Celebrating its 20th year of scientific excellence, Pharmacology & Therapeutics continues to be among the top 10 most cited journals in pharmacology.

　　药理学与治疗学对当前药理学的重要主题进行了清晰、批判性和权威性的评论。由于文章是委托发表的，负责招募作品的编辑会向作者提供指示。《Pharmacology & Therapeutics》庆祝其科学卓越成就 20 周年，继续跻身药理学领域被引用次数最多的 10 种期刊之列。

　　3、PHARMACOLOGICAL REVIEWS

　　学科领域：

　　大类：医学

　　小类：药学

　　中科院分区：1区

　　期刊简介：Pharmacological Reviews presents important review articles covering the broad spectrum of pharmacological research. Topics covered have included biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology, clinical pharmacology, and toxicology. IUPHAR nomenclature reports are published here.

　　药理学评论提供了涵盖广泛药理学研究的重要评论文章。涵盖的主题包括生化和细胞药理学、药物代谢和处置、肾脏药理学、神经药理学、行为药理学、临床药理学和毒理学。IUPHAR 命名法报告在此发布。

　　4、DRUGS

　　学科领域：

　　大类：医学

　　小类：药学

　　中科院分区：1区

　　期刊简介：Stay up to date with the latest developments in therapeutics by reading the world’s most respected source of authoritative drug information. For over 40 years Drugs has been the definitive journal of drugs and therapeutics, providing independent and crucial information authored by leading international clinicians and researchers.

　　Our prestigious and truly international Honorary Editorial Board ensures content of the highest quality to support clinical decision-making.

　　Through a rigorous and comprehensive program of peer-reviewed evaluations, Drugs provides detailed and objective analysis covering the full spectrum of new and established drug therapies in all disease areas.

　　通过阅读世界上最受尊敬的权威药物信息来源，了解治疗学的最新发展。40 多年来，Drugs 一直是药物和治疗学的权威期刊，提供由国际领先的临床医生和研究人员撰写的独立且重要的信息。我们享有盛誉且真正国际化的荣誉编辑委员会确保提供最高质量的内容以支持临床决策。通过严格而全面的同行评审评估计划，Drugs 提供了涵盖所有疾病领域的全方位新药和既定药物疗法的详细客观分析。